$22.9 Billion
The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.$26.14 - $44.37
The lowest and highst price in the last 52 weeks.49.09x
The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.$0.00 (0.0%)
Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).| Market Cap | $22.9 Billion |
| Enterprise Value | $27 Billion |
| Dividend Yield | $0.00 (0.0%) |
| 1 Year Return | +28.4% |
| 52-Week High | $44.37 |
| 52-Week Low | $26.14 |
| Beta | 1.1 |
| Outstanding Shares | 609 Million |
| Avg 30 Day Volume | 4.19 Million |
| P/E Ratio | 49.09 |
| PEG | -14.38 |
| Earnings per Share | $0.79 |
| Price to Sales Ratio | 3.38 |
| Price to Book Ratio | 6.19 |
| Revenue to Enterprise Value | 3.72 |
| EBIT to Enterprise Value | 28.06 |
| Total Debt to Enterprise Value | 0.21 |
| Debt to Equity | 1.36 |
| Revenue | $7.27 Billion |
| Gross Profit | $2.44 Billion |
| EBIT | $963 Million |
| Net Income | $466 Million |
| Profit Margin | 6.4% |
| Quarterly Earnings Growth (YoY) | -341.3% |
| Return on Equity | 11.34% |
| Return on Assets | 3.82% |
| Return on Invested Capital | 8.85% |
No purchases
851,353 shares sold (14 transactions)
300 shares bought (1 transactions)
359,633 shares sold (5 transactions)
No purchases
335,097 shares sold (6 transactions)
No purchases
11,551 shares sold (1 transactions)
CEO: Michael Stubblefield
Employees: 12,400
Industry: Analytical Laboratory Instrument Manufacturing
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
Akoya Biosciences (NASDAQ:AKYA) and Avantor (NYSE:AVTR) are both medical companies, but which is the better stock? We will compare the two companies based on...
Akoya Biosciences (NASDAQ:AKYA) and Avantor (NYSE:AVTR) are both medical companies, but which is the better business? We will contrast the two companies base...
Avantor, Inc. (NYSE:AVTR) has received an average recommendation of Buy from the nineteen brokerages that are covering the stock, MarketBeat reports. One equ...
JPMorgan Chase & Co. initiated coverage on shares of Avantor (NYSE:AVTR) in a research report released on Monday morning, The Fly reports. The firm issued an...
